Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Basal-Cell Carcinoma
100%
Vismodegib
55%
Rhinophyma
48%
Adverse Event
45%
Clinical Trial
41%
Hedgehog Signaling
31%
Psoriasis
27%
Cancer
27%
Papulopustular
24%
Azelaic Acid
24%
Skin Surgery
24%
Gorlin Syndrome
24%
Dermatosis
24%
Psoriatic Arthritis
24%
Genetics
24%
Nevus
22%
Compassionate Use
19%
Quality of Life
18%
Dermatology
17%
Treatment Option
17%
Systematic Review
16%
Skin Manifestation
14%
Skin Cancer
14%
Signal Transduction
13%
Acneiform Eruption
12%
Targeted Therapy
12%
Scar Formation
12%
Skin Biopsy
12%
Chinese (Language)
12%
Emerging Treatment
12%
Prospective Study
12%
Biopsy Technique
12%
Pooled Analysis
12%
Patient-Reported Outcome
12%
Melanoma
10%
Education
9%
Diseases
8%
Dermatological Agent
8%
Clinician
7%
Malignant Neoplasm
7%
Systemic Therapy
7%
Treatment Response
6%
Outcome Assessment
6%
Erythema
6%
Itraconazole
5%
Neoplasm
5%
Infection
5%
Keyphrases
Vismodegib
61%
Advanced Basal Cell Carcinoma
52%
Basal Cell Carcinoma
47%
Adverse Events
38%
Clinical Trials
36%
Rosaceae
24%
Dermatologic Surgery
24%
Core Domain Set
24%
Plasminogen Activator
24%
Clinical Practice
24%
Consensus Statement
24%
Expanded Access
20%
Metastatic Basal Cell Carcinoma
18%
Hedgehog Inhibitor
16%
Adverse Event Rates
15%
Skin Cancer
14%
Skin Diseases
14%
Pooled Analysis
13%
Nevoid Basal Cell Carcinoma Syndrome
12%
Papulopustular Rosacea
12%
Psoriatic Arthritis
12%
Psoriasis
12%
Azelaic Acid
12%
Atopic Dermatitis
12%
Tolerability
12%
Vehicle Control
12%
Randomized Double-blind
12%
Membrane Association
12%
Antipruritic
12%
Ichthyosis Linearis Circumflexa
12%
Uniform Protocol
12%
Alopecia Areata
12%
Nalmefene
12%
Opiods
12%
Antimitotic Agents
12%
Chinese Language
12%
Acne Treatment
12%
Congenital Disorders
12%
Ixekizumab
12%
Chinese Population
12%
DNA Synthesis
12%
Pruritus
12%
Cutaneous Malignancy
12%
Mouse Macrophages
12%
Therapeutic Efficacy
12%
Gorlin Syndrome
12%
Melanoma Patients
12%
Characteristic Event
12%
Acne Scars
12%
Biopsy Rate
12%
Pharmacology, Toxicology and Pharmaceutical Science
Basal Cell Carcinoma
63%
Vismodegib
53%
Hedgehog
31%
Psoriasis
27%
Rosacea
24%
Azelaic Acid
24%
Psoriatic Arthritis
24%
Plasminogen Activator
24%
Nevus
22%
Clinical Trial
17%
Tolerability
15%
Atopic Dermatitis
15%
Acne
12%
Basal Cell Nevus Syndrome
12%
Skin Manifestation
12%
Skin Disease
12%
Antipruritic Agent
12%
Pruritus
12%
Nalmefene
12%
Adverse Event
10%
Colchicine
9%
Vinblastine
6%
Erythema
6%
Nocodazole
6%
Cytochalasin B
6%